Moderate riskFDA DrugClass II

Heritage clindamycin oral solution recalled for foreign particles

Heritage Pharmaceuticals' clindamycin palmitate hydrochloride oral solution (75 mg/5 mL) has been recalled due to the presence of particles and white flakes found in reconstituted bottles. The affected lot is 2411550, which expires November 2026. This product was distributed nationwide.

From the FDA notice · Read the official notice ↗

What to do

  1. Check if you have clindamycin oral solution lot #2411550 (expiration November 2026).
  2. Do not use the product if particles or white flakes are visible.
  3. Contact your pharmacist or doctor for guidance on obtaining a replacement or alternative antibiotic.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only, 100 mL, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-603-51
Sold in
Nationwide
Made for
All ages (0 months and older)

Details

Illnesses reported
None reported
Manufactured in
1 Tower Center Blvd Ste 1700, East Brunswick, NJ, United States
Classification
Class II
Recall number
D-0768-2026

In the FDA's words

Description
CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only, 100 mL, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-603-51 Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles. Lot #: 2411550, Exp. 2026/NOV. Distribution: Nationwide within the U.S
Hazard
Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.

Related topics

ParticulateDrugsSold nationwideMore from FDA Drug